10-121515280-T-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_000141.5(FGFR2):c.1124A>G(p.Tyr375Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 31)
Consequence
FGFR2
NM_000141.5 missense
NM_000141.5 missense
Scores
15
3
1
Clinical Significance
Conservation
PhyloP100: 7.94
Genes affected
FGFR2 (HGNC:3689): (fibroblast growth factor receptor 2) The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), FGFR2. . Gene score misZ 2.402 (greater than the threshold 3.09). Trascript score misZ 4.4365 (greater than threshold 3.09). GenCC has associacion of gene with Pfeiffer syndrome type 3, Antley-Bixler syndrome, Pfeiffer syndrome type 2, Saethre-Chotzen syndrome, Beare-Stevenson cutis gyrata syndrome, Crouzon syndrome, Jackson-Weiss syndrome, Pfeiffer syndrome type 1, LADD syndrome 1, Pfeiffer syndrome, bent bone dysplasia syndrome 1, Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, familial scaphocephaly syndrome, McGillivray type, Apert syndrome, LADD syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.931
PP5
Variant 10-121515280-T-C is Pathogenic according to our data. Variant chr10-121515280-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 13277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-121515280-T-C is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGFR2 | NM_000141.5 | c.1124A>G | p.Tyr375Cys | missense_variant | 9/18 | ENST00000358487.10 | NP_000132.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFR2 | ENST00000358487.10 | c.1124A>G | p.Tyr375Cys | missense_variant | 9/18 | 1 | NM_000141.5 | ENSP00000351276.6 | ||
FGFR2 | ENST00000457416.7 | c.1127A>G | p.Tyr376Cys | missense_variant | 9/18 | 1 | ENSP00000410294.2 | |||
FGFR2 | ENST00000369056.5 | c.1127A>G | p.Tyr376Cys | missense_variant | 8/17 | 1 | ENSP00000358052.1 | |||
FGFR2 | ENST00000369058.7 | c.1127A>G | p.Tyr376Cys | missense_variant | 9/17 | 1 | ENSP00000358054.3 | |||
FGFR2 | ENST00000613048.4 | c.857A>G | p.Tyr286Cys | missense_variant | 8/17 | 5 | ENSP00000484154.1 | |||
FGFR2 | ENST00000369061.8 | c.788A>G | p.Tyr263Cys | missense_variant | 6/15 | 1 | ENSP00000358057.4 | |||
FGFR2 | ENST00000369059.5 | c.782A>G | p.Tyr261Cys | missense_variant | 7/16 | 5 | ENSP00000358055.1 | |||
FGFR2 | ENST00000360144.7 | c.860A>G | p.Tyr287Cys | missense_variant | 8/17 | 2 | ENSP00000353262.3 | |||
FGFR2 | ENST00000478859.5 | c.440A>G | p.Tyr147Cys | missense_variant | 8/17 | 1 | ENSP00000474011.1 | |||
FGFR2 | ENST00000604236.5 | n.*171A>G | non_coding_transcript_exon_variant | 8/17 | 1 | ENSP00000474109.1 | ||||
FGFR2 | ENST00000604236.5 | n.*171A>G | 3_prime_UTR_variant | 8/17 | 1 | ENSP00000474109.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Beare-Stevenson cutis gyrata syndrome Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Randwick Genomics Laboratory, Prince of Wales Hospital Sydney, Australia, New South Wales Health Pathology | - | Recurrent pathogenic: RCV000762799 - |
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Sep 17, 2016 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Department of Medical Genetics, Oslo University Hospital | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2007 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 09, 2024 | - - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 26, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 12000365, 12900900, 23754559, 16531735, 25937001, 17525745, 19610084, 12145519, 27079505, 21397175, 17449949, 35050789, 32158469, 21479481, 8696350, 9545103, 25706251, 20856019) - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Aug 28, 2014 | - - |
FGFR2-related craniosynostosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 17, 2023 | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 375 of the FGFR2 protein (p.Tyr375Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Beare-Stevenson cutis gyrata syndrome (PMID: 8696350, 12145519, 12900900, 16531735, 20856019, 21397175, 25706251, 25937001, 27079505). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 13277). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FGFR2 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
FGFR2-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 13, 2024 | The FGFR2 c.1124A>G variant is predicted to result in the amino acid substitution p.Tyr375Cys. This variant has been well documented to be pathogenic for Beare-Stevenson cutis gyrata syndrome (see for example Przylepa et al. 1996. PubMed ID: 8696350; Fonseca et al. 2008. PubMed ID: 21479481; Wenger et al. 2015. PMID: 25706251; Ron et al. 2016. PubMed ID: 27079505). This variant has also been identified as a de novo variant in an infant with a clinical diagnosis of Pfeiffer syndrome (Willig et al. 2015. PubMed ID: 25937001). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. - |
Acrocephalosyndactyly type I;C0010273:Crouzon syndrome;C0038356:Neoplasm of stomach;C0175699:Saethre-Chotzen syndrome;C0220658:Pfeiffer syndrome;C0265269:Levy-Hollister syndrome;C0795998:Jackson-Weiss syndrome;C1852406:Beare-Stevenson cutis gyrata syndrome;C1865070:Familial scaphocephaly syndrome, McGillivray type;C2936791:Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis;C3281247:Bent bone dysplasia syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Endometrial carcinoma Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2007 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
.;.;.;D;.;.;T;.;T;.;.;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
.;.;.;M;.;.;.;M;.;.;.;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D;.;D;.;D;D;D;.;D;D;D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;.;D;.;D;D;D;.;D;D;D;D;D
Sift4G
Uncertain
D;T;T;D;T;D;T;D;D;D;D;D;D;.
Polyphen
1.0, 1.0, 0.93
.;D;.;D;.;D;.;.;.;.;P;D;.;.
Vest4
MutPred
0.81
.;.;.;Loss of disorder (P = 0.1004);.;.;.;Loss of disorder (P = 0.1004);.;.;.;.;.;.;
MVP
MPC
2.0
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at